Related Experiment Video
Updated: Jun 22, 2025

10:26
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.4K
Dissecting Crucial Gene Markers Involved in HPV-Associated Oropharyngeal Squamous Cell Carcinoma from RNA-Sequencing
Karthik Sekaran1, Rinku Polachirakkal Varghese1, Sasikumar Krishnan2
1School of Biosciences and Technology, Vellore Institute of Technology, 632014 Vellore, India.
Frontiers in Bioscience (Landmark Edition)
|June 28, 2024
Summary
This study identifies seven key genes driving oropharyngeal squamous cell carcinoma (OPSCC) using an integrative genomics approach. These findings offer insights for developing targeted therapies for OPSCC.
Area of Science:
- Genomics
- Oncology
- Bioinformatics
Background:
- Oropharyngeal squamous cell carcinoma (OPSCC) incidence is alarmingly high worldwide.
- Understanding OPSCC etiology is crucial for effective treatment strategies.
Purpose of the Study:
- To identify key oncogenic drivers in OPSCC pathogenesis using an integrative genomics approach.
- To develop predictive models for OPSCC using machine learning algorithms.
Main Methods:
- RNA-Sequencing (RNA-Seq) data from 46 HPV-positive OPSCC and 25 normal samples were analyzed.
- Differential gene expression analysis identified 714 candidate genes, reduced to 73 using Particle Swarm Optimization (PSO).
- Machine learning algorithms were trained on gene subsets to identify key drivers.
Main Results:
- Seven genes, including ECT2, LAMC2, DSG2, FAT1, PLOD2, COL1A1, and PLAU, were identified as significant contributors to OPSCC.
- Machine learning models achieved perfect validation scores using PSO-selected features.
- Gene set enrichment, protein-protein interaction, and disease ontology analyses confirmed the association of these genes with OPSCC.
Conclusions:
- The study elucidates critical oncogenic drivers in OPSCC.
- These findings provide vital insights for developing targeted therapies and understanding OPSCC pathogenesis.
Keywords:
RNA-sequencingbiomarker discoveryexplainable artificial intelligencehuman papillomavirusoropharyngeal squamous cell carcinomashapley additive explanationsMore Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K

